CMS Final Fee Schedule Will Impact Patient Access to Laboratories: COLA
From - Diagnostic Testing & Emerging Technologies The CMS Final Fee Schedule will hurt patient access to clinical laboratories, says the lab accreditation bureau COLA… . . . read more
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article